Serum Institute says Covishield production increased to 110 million doses in July
Pune/IBNS: Serum Institute of India (SII) said Tuesday the production of Covishield has been ramped up to 110 million doses this month, according to media reports.
"The commitment to produce 100-110 million doses of Covishield by July has been achieved," Serum Institute sources told NDTV.
Additionally, SII is also going to produce Russia's Sputnik V vaccine from September and it is also gearing up to rollout of the Covovax (Novavax) vaccine, which is yet to get Emergency Use Authorisation.
Currently, Covishield and Covaxin are the two vaccines used in India's massive Covid-19 vaccination drive.
The Central government aims to vaccinate all adults by the end of 2021.